Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Work In Process (2016 - 2018)

Historic Work In Process for Sanofi (SNY) over the last 4 years, with Q4 2018 value amounting to $4.7 billion.

  • Sanofi's Work In Process rose 733.7% to $4.7 billion in Q4 2018 from the same period last year, while for Dec 2018 it was $4.7 billion, marking a year-over-year increase of 733.7%. This contributed to the annual value of $4.7 billion for FY2018, which is 1190.89% up from last year.
  • According to the latest figures from Q4 2018, Sanofi's Work In Process is $4.7 billion, which was up 733.7% from $4.3 billion recorded in Q4 2017.
  • Sanofi's 5-year Work In Process high stood at $4.7 billion for Q4 2018, and its period low was $3.8 billion during Q4 2015.
  • Over the past 4 years, Sanofi's median Work In Process value was $4.2 billion (recorded in 2016), while the average stood at $4.2 billion.
  • Its Work In Process has fluctuated over the past 5 years, first soared by 755.71% in 2016, then soared by 589.44% in 2017.
  • Sanofi's Work In Process (Quarter) stood at $3.8 billion in 2015, then grew by 7.56% to $4.1 billion in 2016, then grew by 5.89% to $4.3 billion in 2017, then increased by 7.34% to $4.7 billion in 2018.
  • Its Work In Process stands at $4.7 billion for Q4 2018, versus $4.3 billion for Q4 2017 and $4.1 billion for Q4 2016.